Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck EBITDA Margin 2010-2025 | MKKGY

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Merck (MKKGY) over the last 10 years. The current EBITDA margin for Merck as of March 31, 2025 is .
  
Merck EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $22.90B $6.31B 27.56%
2024-12-31 $22.89B $6.26B 27.32%
2024-09-30 $22.74B $6.02B 26.47%
2024-06-30 $22.58B $5.84B 25.85%
2024-03-31 $22.60B $5.85B 25.87%
2023-12-31 $22.72B $5.94B 26.15%
2023-09-30 $22.91B $6.34B 27.65%
2023-06-30 $23.13B $6.45B 27.91%
2023-03-31 $23.27B $6.65B 28.59%
2022-12-31 $23.42B $6.85B 29.26%
2022-09-30 $23.58B $7.01B 29.70%
2022-06-30 $23.60B $7.08B 30.01%
2022-03-31 $23.54B $7.06B 29.98%
2021-12-31 $23.29B $7.03B 30.17%
2021-09-30 $22.79B $6.52B 28.61%
2021-06-30 $22.12B $6.74B 30.46%
2021-03-31 $20.79B $6.13B 29.47%
2020-12-31 $20.03B $5.62B 28.07%
2020-09-30 $19.42B $5.58B 28.74%
2020-06-30 $18.73B $4.81B 25.66%
2020-03-31 $18.66B $4.85B 25.99%
2019-12-31 $18.09B $4.55B 25.16%
2019-09-30 $17.42B $4.34B 24.88%
2019-06-30 $17.27B $4.19B 24.28%
2019-03-31 $17.24B $3.98B 23.10%
2018-12-31 $17.52B $4.18B 23.85%
2018-09-30 $17.87B $4.02B 22.46%
2018-06-30 $17.90B $4.59B 25.63%
2018-03-31 $17.75B $4.72B 26.61%
2017-12-31 $17.32B $4.84B 27.94%
2017-09-30 $16.90B $5.05B 29.85%
2017-06-30 $16.68B $4.66B 27.93%
2017-03-31 $16.70B $4.76B 28.48%
2016-12-31 $16.63B $4.89B 29.40%
2016-09-30 $16.29B $4.75B 29.13%
2016-06-30 $15.63B $4.54B 29.08%
2016-03-31 $14.89B $4.25B 28.54%
2015-12-31 $14.31B $3.78B 26.39%
2015-09-30 $13.91B $3.51B 25.23%
2015-06-30 $14.32B $3.50B 24.42%
2015-03-31 $14.59B $3.52B 24.15%
2014-12-31 $14.78B $3.64B 24.62%
2014-09-30 $15.11B $4.17B 27.62%
2014-06-30 $14.86B $4.42B 29.77%
2014-03-31 $14.80B $4.76B 32.19%
2013-12-31 $14.72B $4.82B 32.72%
2013-09-30 $14.64B $7.31B 49.91%
2013-06-30 $14.55B $6.65B 45.70%
2013-03-31 $14.30B $5.44B 38.02%
2012-12-31 $14.00B $7.60B 54.31%
2012-09-30 $13.66B $7.27B 53.18%
2012-06-30 $13.69B $10.25B 74.86%
2012-03-31 $13.85B $10.32B 74.54%
2011-12-31 $14.08B $10.55B 74.95%
2011-09-30 $14.47B $10.95B 75.64%
2011-06-30 $14.03B $7.98B 56.87%
2011-03-31 $13.05B $10.53B 80.64%
2010-12-31 $12.34B $9.81B 79.52%
2010-09-30 $11.61B $9.09B 78.24%
2010-06-30 $11.25B $11.25B 100.00%
2010-03-31 $11.14B $11.14B 100.00%
2009-12-31 $10.81B $10.81B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $17.015B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $70.494B 27.11
Zoetis (ZTS) United States $69.411B 25.18
Takeda Pharmaceutical (TAK) Japan $49.383B 10.08
Daiichi Sankyo, - (DSNKY) Japan $48.268B 24.74
BeOne Medicines - (ONC) Switzerland $34.378B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.623B 0.00
Summit Therapeutics (SMMT) United States $19.463B 0.00
Shionogi (SGIOY) Japan $14.904B 14.93
United Therapeutics (UTHR) United States $14.084B 12.19
Neurocrine Biosciences (NBIX) United States $13.432B 40.07
IPSEN (IPSEY) France $11.429B 0.00
Orion OYJ (ORINY) Finland $11.336B 27.32
Eisai (ESAIY) $9.286B 10.47
Madrigal Pharmaceuticals (MDGL) United States $9.207B 0.00
Corcept Therapeutics (CORT) United States $7.411B 62.24
Grifols, S.A (GRFS) Spain $6.986B 0.00
Stevanato Group S.p.A (STVN) Italy $6.850B 40.39
Ionis Pharmaceuticals (IONS) United States $6.804B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Soleno Therapeutics (SLNO) United States $3.644B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.225B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.012B 14.31
Crinetics Pharmaceuticals (CRNX) United States $2.912B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.816B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.580B 8.64
Hypermarcas (HYPMY) Brazil $2.540B 19.10
Centessa Pharmaceuticals (CNTA) United Kingdom $2.278B 0.00
Ocular Therapeutix (OCUL) United States $2.140B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.797B 0.00
Dyne Therapeutics (DYN) United States $1.790B 0.00
Guardian Pharmacy Services (GRDN) United States $1.633B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.615B 24.06
Avadel Pharmaceuticals (AVDL) Ireland $1.480B 0.00
Ardelyx (ARDX) United States $1.472B 0.00
Harrow (HROW) United States $1.448B 0.00
ARS Pharmaceuticals (SPRY) United States $1.334B 0.00
Evotec AG (EVO) Germany $1.293B 0.00
Xeris Biopharma Holdings (XERS) United States $1.251B 0.00
Enliven Therapeutics (ELVN) United States $1.235B 0.00
Collegium Pharmaceutical (COLL) United States $1.232B 6.73
Cronos Group (CRON) Canada $0.996B 0.00
Akebia Therapeutics (AKBA) United States $0.846B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.829B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.744B 7.67
ProKidney (PROK) United States $0.705B 0.00
Theravance Biopharma (TBPH) United States $0.701B 57.96
KalVista Pharmaceuticals (KALV) United States $0.670B 0.00
Siga Technologies (SIGA) United States $0.654B 8.08
Relay Therapeutics (RLAY) United States $0.636B 0.00
Bioventus (BVS) United States $0.632B 15.28
Organogenesis (ORGO) United States $0.620B 0.00
Xencor (XNCR) United States $0.600B 0.00
Tourmaline Bio (TRML) United States $0.599B 0.00
USANA Health Sciences (USNA) United States $0.589B 12.07
Elite Pharmaceuticals (ELTP) United States $0.588B 0.00
Oruka Therapeutics (ORKA) United States $0.578B 0.00
Savara (SVRA) United States $0.546B 0.00
Zevra Therapeutics (ZVRA) United States $0.530B 0.00
Nektar Therapeutics (NKTR) United States $0.514B 0.00
Nanobiotix S.A (NBTX) France $0.484B 0.00
Esperion Therapeutics (ESPR) United States $0.438B 0.00
Aquestive Therapeutics (AQST) United States $0.397B 0.00
Aldeyra Therapeutics (ALDX) United States $0.348B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.333B 0.00
4D Molecular Therapeutics (FDMT) United States $0.331B 0.00
Larimar Therapeutics (LRMR) United States $0.324B 0.00
Altimmune (ALT) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.289B 18.85
AleAnna (ANNA) United States $0.275B 0.00
Lexeo Therapeutics (LXEO) United States $0.265B 0.00
Galectin Therapeutics (GALT) United States $0.263B 0.00
OmniAb (OABI) United States $0.227B 0.00
Heron Therapeutics (HRTX) United States $0.215B 0.00
Lyell Immunopharma (LYEL) United States $0.207B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.206B 31.75
Aclaris Therapeutics (ACRS) United States $0.195B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Korro Bio (KRRO) United States $0.188B 0.00
China SXT Pharmaceuticals (SXTC) China $0.182B 0.00
Journey Medical (DERM) United States $0.174B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
MEI Pharma (MEIP) United States $0.161B 0.00
Achieve Life Sciences (ACHV) Canada $0.149B 0.00
Profound Medical (PROF) Canada $0.142B 0.00
Inhibikase Therapeutics (IKT) United States $0.141B 0.00
Avalo Therapeutics (AVTX) United States $0.130B 0.00
Avita Medical (RCEL) United States $0.130B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.120B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.105B 23.84
Dominari Holdings (DOMH) United States $0.100B 0.00
Surrozen (SRZN) United States $0.098B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
Liminatus Pharma (LIMN) United States $0.089B 0.00
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Pyxis Oncology (PYXS) United States $0.083B 0.00
Context Therapeutics (CNTX) United States $0.080B 0.00
VAXART, INC (VXRT) United States $0.079B 0.00
Wellgistics Health (WGRX) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.076B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Vivani Medical (VANI) United States $0.073B 0.00
Metagenomi (MGX) United States $0.072B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Gain Therapeutics (GANX) United States $0.071B 0.00
Prelude Therapeutics (PRLD) United States $0.070B 0.00
Inotiv (NOTV) United States $0.065B 0.00
DURECT (DRRX) United States $0.060B 0.00
PolyPid (PYPD) Israel $0.056B 0.00
Rafael Holdings (RFL) United States $0.055B 0.00
Karyopharm Therapeutics (KPTI) United States $0.055B 0.00
Jupiter Neurosciences (JUNS) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.052B 0.00
Fractyl Health (GUTS) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.91
Plus Therapeutics (PSTV) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Klotho Neurosciences (KLTO) United States $0.046B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Tempest Therapeutics (TPST) United States $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.043B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
CASI Pharmaceuticals (CASI) China $0.029B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Natural Alternatives (NAII) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Mangoceuticals (MGRX) United States $0.018B 0.00
Incannex Healthcare (IXHL) Australia $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Scienture Holdings (SCNX) United States $0.017B 0.00
Ainos (AIMD) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Aptorum Group (APM) United Kingdom $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Carisma Therapeutics (CARM) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
CDT Equity (CDT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.66
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.65
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00